文献速递血栓与止血

首次近端或孤立性远端深静脉血栓且无肺栓塞患者的生存与复发性静脉血栓栓塞症

Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism.
PubMed 文献 · J Thromb Haemost · 2017-05-24

单中心队列纳入831例首次症状性近端深静脉血栓(PDVT,629例)或孤立性远端深静脉血栓(IDDVT,202例)且无肺栓塞患者,中位随访7.6年。IDDVT患者复发性PDVT或肺栓塞风险低于PDVT(aHR 0.32,95%CI 0.19-0.55),死亡风险似较低(aHR 0.75,95%CI 0.55-1.02),特发性事件后尤为明显。

要点

  • IDDVT患者复发性PDVT或肺栓塞风险低于PDVT患者(aHR 0.32)。
  • IDDVT患者长期死亡风险似较低(aHR 0.75,95%CI 0.55-1.02)。
  • 特发性事件后IDDVT死亡风险似更低(aHR 0.58,95%CI 0.26-1.31)。

核心结论

  • 与近端深静脉血栓相比,孤立性远端深静脉血栓患者复发性静脉血栓栓塞症风险较低;在中位随访7.6年期间,孤立性远端深静脉血栓后死亡风险似较低。

研究设计与样本

  • 单中心队列研究,筛查4759份记录,纳入831例首次症状性急性近端深静脉血栓或孤立性远端深静脉血栓患者;排除合并肺栓塞或既往静脉血栓栓塞症者。
  • 孤立性远端深静脉血栓组202例,近端深静脉血栓组629例;中位年龄66岁,女性占50.5%。

主要发现

  • 随访3175患者年期间,125例发生复发性近端深静脉血栓或肺栓塞:近端深静脉血栓组109例(17.3%),孤立性远端深静脉血栓组16例(7.9%)。
  • 年复发率分别为近端深静脉血栓组4.5%(95%CI 3.7-5.4%) vs 孤立性远端深静脉血栓组2.0%(95%CI 1.1-3.2%),孤立性远端深静脉血栓调整后风险比(aHR)为0.32(95%CI 0.19-0.55)。
  • 随访5469患者年期间,263例死亡(31.6%,95%CI 28.6-34.9%),总体年死亡率为4.8%(95%CI 4.2-5.4%);近端深静脉血栓组死亡率33.5%(211例),孤立性远端深静脉血栓组25.7%(52例)。
  • 孤立性远端深静脉血栓患者长期死亡风险似较低(aHR 0.75,95%CI 0.55-1.02),特发性事件后尤为明显(aHR 0.58,95%CI 0.26-1.31)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials The long-term risk of recurrence and death after distal deep vein thrombosis (DVT) is uncertain. We included subjects with first proximal or isolated distal DVT (IDDVT) and no pulmonary embolism. The risk of symptomatic and asymptomatic recurrence is lower after IDDVT (vs. proximal). IDDVT may be associated with a lower long-term risk of death, especially after unprovoked DVT. SUMMARY: Background A few studies have focused on the risk of recurrence after first acute isolated distal deep vein thrombosis (IDDVT) compared with proximal DVT (PDVT), whereas the incremental risk of death has never been explored beyond the first 3 years after acute event. Methods Our single-center cohort study included patients with first symptomatic acute PDVT or IDDVT. Patients were excluded if they had concomitant pulmonary embolism (PE) or prior venous thromboembolism. The primary outcomes were symptomatic objectively diagnosed recurrent PDVT or PE and all-cause death. Results In total, 4759 records were screened and 831 subjects included: 202 had symptomatic IDDVT and 629 had PDVT. The median age was 66 years and 50.5% were women. A total of 125 patients had recurrent PDVT or PE during 3175 patient-years of follow-up: 109 events occurred after PDVT (17.3%) and 16 after IDDVT (7.9%). Annual recurrence rates were 4.5% (95% confidence interval [CI], 3.7-5.4%) and 2.0% (95% CI, 1.1-3.2%), respectively, for an adjusted hazard ratio (aHR) for IDDVT patients of 0.32 (95% CI, 0.19-0.55). Death occurred in 263 patients (31.6% [95% CI, 28.6-34.9%]) during 5469 patient-years of follow-up for an overall annual incidence rate of 4.8% (95% CI, 4.2-5.4%). The mortality rate was 33.5% (n = 211) in PDVT patients and 25.7% (n = 52) in IDDVT patients. The long-term hazard of death appeared lower for IDDVT patients (aHR, 0.75 [95% CI, 0.55-1.02]), especially after unprovoked events (aHR, 0.58 [95% CI, 0.26-1.31]). Conclusions Compared with PDVT, IDDVT patients were at a lower risk of recurrent VTE. The risk of death appeared lower after IDDVT during a median follow-up of 7.6 years.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Barco S, Corti M, Trinchero A, et al. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost. 2017. PMID: 28439954. doi:10.1111/jth.13713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。